JPK boosts its position in Molecular Analytics with complete takeover of nAmbition subsidiary
JPK Instruments AG has increased its share in JPK subsidiary nAmbition GmbH in Dresden to 100 percent. Thus the Berlin-based company was able to extend its product portfolio and significantly boost its Molecular analytics division.
Founded in 2004, nAmbition develops, products and markets analytical instruments based on nanotechnological methods. The company is thus positioned in the rapidly growing market for instruments and techniques used in nanobiotechnology and molecular biology.
"The complete takeover of nAmbition now provides us with an opportunity to exploit major synergy potential. We will integrate nAmbition into our overall marketing and sales structure and further boost its sales and earnings contributions," comments Frank Pelzer, CEO of JPK Instruments AG, with regard to the acquisition of shares from investment company Dresden Fonds GmbH, which has actively accompanied the development of nAmbition as a financing partner since 2005.
According to the company, the development expertise and products of nAmbition ideally complement JPK's portfolio and will significantly strengthen its Molecular Analytics division. Besides growth in sales and long-term improvement of earnings, the Berlin-based company also expects the acquisition to be helpful in winning new customer groups.
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
